“…5) that sulforaphane interacts with the heme moiety of cytochromes P450, with relatively modest specificity (KS = 6.76 ± 0.93 µM for racemic sulforaphane), it may well bind also to the heme of the respective NO synthase as both these proteins are known to exhibit similar properties of the heme (Renaud, Boucher, Vadon, Delaforge, & Mansuy, 1993). Interestingly, the inhibition of CYP enzymes in human microsomes occurred with the forms with better accessibility of the heme group: CYP3A4 and CYP2D6 (Hendrychova et al, 2011); on the other hand, in hepatocytes, all the CYP forms studied were inhibited which may indicate better access of the sulforaphane to the CYP active sites in their natural neighborhood (endoplasmic reticulum) than in artificially formed vesicles of microsomes. An alternative explanation of the inhibition of CYP activities in hepatocytes may stem from the fact that sulforaphane has been shown to accumulate in the cells; and, hence, the sulforaphane level inside the cell may reach toxic levels being at least one order of magnitude higher than in the surrounding medium (Ye et al, 2002;Zhang, 2000).…”